See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Not accepting new patients
Perelman Center for Advanced Medicine
West Pavilion, 4th Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Posttransplant Lymphoproliferative Disorder
Nagle SJ, Shah NN, Ganetsky A, Landsburg DJ, Nasta SD, Mato A, Schuster SJ, Reshef R, Tsai DE, Svoboda J.: Long term outcomes of rituximab, temozolomide, and high-dose methotrexate without consolidation therapy for lymphoma involving the central nervous system Int J Hematol Oncol : 2017.
Kremer B, Tsai DE, Debonera F, Cohen P, Schuster SJ.: Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide. Leuk Lymphoma 11 : 1-3,2017.
Debonera F, Nasta S, Martinez-Lage M, Schuster SJ, Tsai DE.: Primary diffuse large B-cell lymphoma of the central nervous system: A rare case of spontaneous remission. Int J Hematol Oncol : 2017.
Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, Porter DL, Vonderheide RH, Bagg A, Heitjan DF, Tsai DE, Reshef R.: The impact of EBV status on characteristics and outcomes of Posttransplant lymphoproliferative disorder. Am J Transplant 15 : 2665-2673,2015.
Tsai DE, Luskin MR, Kremer BE, Chung AK, Arnoldi S, Paralkar VR, Nasta SD, , Stadtmauer EA, Schuster SJ, Xavier M.: A pilot trial of quantitative EBV PCR in patients undergoing treatment for their malignancy: potential use of EBV PCR in multiple cancer types. Leukemia & Lymphoma 56 : 1530-1532,2015.
Paul TM, Liu SV, Chong EA, Luger SM, Porter DL, Schuster SJ, Tsai DE, Nasta, SD, Loren A, Frey N, Perl A, Cohen AD, Weiss BM, Stadtmauer EA, Vogl DT.: Outpatient autologous stem cell transplantation for patients with multiple
Clin Lymphoma Myeloma Leuk 15 : 536-540,2015.
Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL.: Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer 120 : 2464-2471,2014.
Ellebrecht CT, Choi EJ, Allman DM, Tsai DE, Wegener WA, Goldenberg DM, Payne AS: Subcutaneous veltuzumab, a humanized anti-CD20 antibody, for treatment of refractory pemphigus vulgaris. JAMA Dermatology 150 : 1331-1335,2014.
Karuturi M, Shah N, Frank D, Fasan O, Reshef R, Ahya VN, Bromberg M, Faust T, Goral S, Schuster SJ, Stadtmauer EA, Tsai DE: Plasmacytic Posttransplant lymphoproliferative disorder: a case series of nine patients. Transplant International 26 : 616-622,2013.
Landsburg DJ, Stadtmauer E, Loren A, Goldstein S, Frey N, Nasta SD, Porter DL, Tsai DE, Perl AE, Hexner EO, Luger S: Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens. American Journal of Hematology 88 : 657-660,2013.
Division of Hematology Oncology Perelman Center for Advanced Medicine12th Floor, South PavilionOffice #12-1563400 Civic Center Boulevard
Patient appointments: 800-789-7366